shutterstock_1036579204.png

Harnessing the body's
natural immune regulation

 

About    

Azora Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule new chemical entities for the treatment of autoimmune, inflammatory diseases. Our team has decades of experience in drug development and has helped develop groundbreaking medicines for patients, including Uceris®, Tysabri®, Ycanth® and Humira®.

 

Leadership

Co-Founder and
Chief Executive Officer

Matt Davidson, PhD

linkedin.png

Co-Founder and
Chief Operating Officer

Julie Saiki, PhD

 

linkedin.png
Advisors

Dennis Brown, PhD
Bill Forbes, PharmD
Lyn Frumkin, MD, PhD
Mike Grissinger
Carol Karp

 

linkedin.png
linkedin.png
linkedin.png
linkedin.png
linkedin.png
Berkeley Limketkai, MD, PhD
Robert Lum, PhD
Marty Okun, MD
Steve Schow, PhD
Larry Steinman, MD
linkedin.png
linkedin.png
linkedin.png
linkedin.png
linkedin.png

Contact    

  • LinkedIn
  • Facebook